Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Am J Hematol. 2015 Jan 30;90(4):334–338. doi: 10.1002/ajh.23939

Figure 3.

Figure 3

(A) Overall Survival of CLL/HL patients (from the time of diagnosis of Hodgkin lymphoma) compared to patients with de novo Hodgkin lymphoma. (B) Overall survival of CLL/HL patients (from the time of diagnosis of Hodgkin lymphoma) compared to de novo HL according to the International Prognostic Score of 0–3. (C) Overall survival of CLL/HL patients (from the time of diagnosis of Hodgkin lymphoma) compared to de novo HL according to the International Prognostic Score of 4–7.